Home Africa News Shareholders File Class-Action Against Struggling EV Bus Manufacturer

Shareholders File Class-Action Against Struggling EV Bus Manufacturer

Share
shareholders-file-class-action-against-struggling-ev-bus-manufacturer
Shareholders File Class-Action Against Struggling EV Bus Manufacturer
Share

Quebec-based electric-vehicle manufacturer Lion Electric Co. is facing a class-action lawsuit from shareholders who allege the company misled investors and misrepresented its financial health.

The proposed lawsuit claims Lion Electric hid facts and details about its order book and production capacities from investors.

Shareholders say the company’s alleged actions led to huge financial losses for them, claiming that when Lion Electric’s struggles became public the stock lost 96 percent of its value on the Toronto and New York stock exchanges.

Among those named in the suit are directors, officers, auditors and underwriters of the company.

Lion Electric obtained protection from its creditors in December and is seeking a buyer with a restructuring plan that would focus only on school buses and return all manufacturing to Quebec.

The allegations in the class action, which was filed with the Quebec Superior Court in Montreal on Friday, have not been tested and the lawsuit has not yet been authorized.

Related Stories

Lion Electric Creditor Protection Extended to April Amid Search for Buyer
Quebec EV Company Lion Electric Made Big Promises, but Struggled to Deliver

Lion Electric wasn’t immediately available for comment.

Share
Related Articles
iceland-focuses-on-security-partnerships-after-voters-reject-opening-eu-membership-talks
China NewsEuropeGlobalWorld News

Iceland Focuses on Security Partnerships After Voters Reject Opening EU Membership Talks

Icelandic Minister for Foreign Affairs Thorgerdur Katrin Gunnarsdottir attends a press conference...

vaccine-maker-halts-trial-on-mrna-cancer-shot
China NewsEuropeGlobalWorld News

Vaccine Maker Halts Trial on mRNA Cancer Shot

A pharmacist administers the Pfizer-BioNTech vaccine in Los Angeles, Calif., on October...